Evidence map›Paper›PMID 38939757›Full record

ReviewJPhys photonics2024

Current state of stimulated Brillouin scattering microscopy for the life sciences.

Alberto Bilenca, Robert Prevedel, Giuliano Scarcelli

Abstract readReview
In one paragraph

Review in JPhys photonics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Brillouin microscopy in cancer research: a review.Journal of biomedical optics · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alberto BilencaBiomedical Engineering Department, Ben-Gurion University of the Negev, 1 Ben Gurion Blvd, Be'er-Sheva 84105, Israel.ORCID https://orcid.org/0000-0003-3320-4731
Robert PrevedelCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Giuliano ScarcelliFischell Department of Bioengineering, University of Maryland, College Park, MD 20742, United States of America.ORCID https://orcid.org/0000-0002-1736-077X

Funding

Cornea biomechanical analysis with Brillouin microscopyR01EY028666 · NEI · UNIV OF MARYLAND, COLLEGE PARK · PI James Bradley Randleman, Giuliano Scarcelli · 2018 to 2026
$4.1M
Biomechanics of accommodationR01EY030063 · NEI · UNIVERSITY OF HOUSTON · PI LARIN, KIRILL V, MANNS, FABRICE · 2020 to 2024
$3.0M
Stimulated Brillouin Flow Cytometry for biomechanical assessment of metastatic potentialR21CA258008 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI KONSTANTOPOULOS, KONSTANTINOS, MARTIN, STUART S · 2022 to 2023
$543k
NCI NIH HHS R21 CA258008NEI NIH HHS R01 EY028666NEI NIH HHS R01 EY030063
6 · The paper itself

Abstract

Stimulated Brillouin scattering (SBS) microscopy is a nonlinear all-optical imaging method that provides mechanical contrast based on the interaction of laser radiation and acoustical vibrational modes. Featuring high mechanical specificity and sensitivity, three-dimensional sectioning, and practical imaging times, SBS microscopy with (quasi) continuous wave excitation is rapidly advancing as a promising imaging tool for label-free visualization of viscoelastic information of materials and living biological systems. In this article, we introduce the theory of SBS microscopy and review the current state-of-the-art as well as recent innovations, including different approaches to system designs and data analysis. In particular, various performance parameters of SBS microscopy and its applications in the life sciences are described and discussed. Future perspectives for SBS microscopy are also presented.

Indexed as

biomechanical imagingoptical microscopystimulated Brillouin scattering

Identifiers

PMID38939757
PMCPMC11200595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.